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Riboflavin or vitamin B2 is the main biochemical 
source of a flavin moiety in the cell, readily forming flavin 
mononucleotide (FMN) and flavinadenine dinucleotide 
(FAD), which play a vital role in the cellular metabolism. 
Riboflavin is involved in such cell metabolic process like 
cellular respiration – the process in which biochemical 
energy from nutrients is converted into adenosine 
triphosphate (ATP).  
Riboflavin was discovered in 1920, isolated in 1933 
and first synthesized in 1935. Riboflavin is on the World 
Health Organization's List of Essential Medicines. 
Besides its key role in providing cellular 
metabolism in humans and animals via dietary 
supplementation, riboflavin as a photosensitizer is used in 
disinfection systems, which provides antimicrobial effects. 
This disinfection technique, in which photosensitizer is 
applied, called antimicrobial photodynamic therapy (aPDT).  
Antimicrobial photodynamic therapy (aPDT) is a 
promising approach for the photoinactivation of pathogens 
in blood and blood derivatives. It has been reported, that the 
advantage of antimicrobial photodynamic therapy is that 
there are no resistant strains to it. For now, there are three 
photosensitizers have been approved: methylene blue (MB) 
for plasma and riboflavin and amotosalen for plasma and 
platelets [1].  
Photochemical mechanisms applied in 
photodynamic therapy 
In its ground state a photosensitizer molecule (PS) 
is a singlet because it has two electrons with opposite spins. 
Absorption of a photon of light (hv) with the appropriate 
quantum energy (with appropriate wavelength) leads to the 
excitation of one electron into a higher-energy orbital 
(Figure 1). This singlet excited-state PS is unstable and loses 
its excess energy either as emission of light (fluorescence) or 
production heat (internal conversion). The excited singlet PS 
may undergo a process known as ‘intersystem crossing’(IC) 
to form a more stable excited triplet state with parallel spins. 
The triplet-state PS molecule can decay back to the ground 
state (by emitting a phosphorescent photon) but this is a 
‘forbidden process’ by the quantum selection rules, so the 
triplet state is much more stable than the singlet state having 
a lifetime of microseconds compared with only nanoseconds 
for the excited singlet. This long lifetime of the triplet state 
allows it sufficient time to transfer its energy by colliding 
with molecular oxygen (O2), which is unique in being a 
molecular triplet in its ground state. This energy-transfer step 
leads to the formation of singlet oxygen (1O2) (and ground-
state PS), and the reaction is referred to as a Type II 
photochemical process. A Type I photochemical process can 
also occur whereby the excited-state PS undergoes electron 
transfer reactions that eventually forms reactive oxygen 
species (ROS). This mechanism may involve either 
acquisition or donation of an electron to form the radical 
cation or radical anion. The radical anion can react with 
oxygen to produce the superoxide radical anion (O2•−). 
Dismutation or one-electron reduction of O2•− gives 
hydrogen peroxide (H2O2), which in turn can undergo 
another one-electron reduction to form the powerful oxidant 
– hydroxyl radicals (HO•). ROS generation via Type II 
mechanism is much simpler than via Type I, and most PSs 
used, for instance, in anti-cancer PDT are believed to operate 
via the Type II rather than the Type I mechanism [2]. 
Riboflavin and antimicrobial photodynamic 
inactivation  
Riboflavin is naturally occurring (not synthetical) 
compound of antimicrobial photodynamic therapy as an 
antimicrobial photosensitizer with two peaks in the UVA 
(360 nm) and blue (440 nm) regions. [ 3 ]. Owing to 
antimicrobial properties have been identified for riboflavin it 
finds its application in blood product sterilization [4] and also 
acts well as a photoactivated cross-linker for corneal 
stiffening in patients with keratoconus and other ectatic 
corneal disorders [5;6].  
The cationic version of riboflavin, which basically 
act as antimicrobial photosensitizer was designed and 
synthesized by Maisch et al [7]. 
 
 
Figure 1. Riboflavin structure
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Figure 2- Jablonski diagram showing photochemical pathways in aPDI. The ground state 1PS (photosensitizer) absorbs 
a photon to form excited singlet state 1PS* that can undergo intersystem crossing (IC) to form the triplet state 3PS*. This 
long-lived species can undergo energy transfer (Type II) to form singlet oxygen 1O2* or electron transfer (Type I) to form 




Flavins are photoreducible, i.e. capable of charge 
transfer per photon absorption, which mediates the cell 
signaling or gene expression in endogenous protein 
complexes, such as light-oxygen-voltage-sensing domains in 
bacteria and plants [ 9 ]. At the same time, biologically-
unregulated photon-induced excitation of flavins in the 
ultraviolet-blue (UV-blue) spectral band can lead to 
formation of either singlet oxygen (1O2) via energy transfer 
to environmental oxygen (Type II), or hydrogen peroxide 
and derivatives via radicalisation (Type I) – altogether 
termed reactive oxygen species (ROS) and used hereafter 
[10].  
The ROS production property of riboflavin is 
known for a long time and used for antiviral and antibacterial 
disinfection; for strengthening the corneal tissue in 
photorefractive surgery by the ROS-induced collagen cross-
linking [11;12]. 
Riboflavin on account of having different meso-
atoms possess excellent photophysical and photochemical 
properties [ 13 ]. Several studies show that photoactivated 
riboflavin does produce ROS [ 14 ; 15 ]. Riboflavin absorbs 
photons from the illuminated light and undergoes 
intersystem conversion i.e. from singlet state to triplet state. 
This triplet state reacts with molecular oxygen, thereby 
producing ROS. This generated ROS attacks cellular 
macromolecules and disintegrates membrane integrity, 
thereby, killing the organism. 
The study of Khan S. et al. demonstrated 
the antimicrobial photodynamic potential of riboflavin 
irradiated with white light for 2 h by using a study model 
with Escherichia coli. The treated bacterial cells exhibited 
abundant intracellular ROS generation and marked 
increment in the level of oxidative stress markers - lipid 
peroxidation (MDA level) and protein carbonylation - as 
well as significant reduction in lactate dehydrogenase (LDH) 
activity. Marked reduction in colony forming units of E.coli 
was also observed, that was further confirmed by optical 
microscopic and SEM images via registration of the bacterial 
death. Thus, this study shows that 
photoilluminated riboflavin renders the redox status of 
bacterial cells into a compromised state leading to significant 
membrane damage ultimately causing bacterial death.  The 
activity of superoxide dismutase (SOD) and catalase, 
significantly reduced in samples which are exposed to 
photoilluminated riboflavin as compared to samples which 
are exposed to riboflavin without light and exposed to light 
alone. The decrease in the level of cellular antioxidant 
metabolite - glutathione (GSH) was significantly reduced in 
samples exposed to photoilluminated riboflavin. The specific 
activity of glutathione S-transferase (GST) - the GSH 
utilizing enzyme that is involved in detoxification process - 
was increased significantly in cells exposed to 
photoilluminated riboflavin. This study adds another 
dimension to the use of photoactivated riboflavin, 
demonstrating that clinically important multi-drug resistant 
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bacteria are susceptible to ROS generated by photoactivated 
riboflavin [16]. 
The study of Maisch T. et al shows that synthesized 
flavin derivatives are able to be used as photosensitizers for 
topical application to decolonize bacteria from skin and 
mucosa. The synthesized flavin derivatives showed a high 
quantum yield of singlet oxygen of approximately 75 %. 
Multidrug resistant bacteria like MRSA (methicillin resistant 
Staphylococcus aureus), EHEC (enterohemorrhagic 
Escherichia coli), Pseudomonas aeruginosa, and 
Acinetobacter baumannii were incubated with flavin 
derivatives in vitro and were subsequently irradiated with 
visible light for seconds only. After irradiation, the number 
of viable bacteria decreased up to 6 log10 steps depending on 
the concentration of the flavin derivatives and the light 
dosimetry. The bactericidal effect of PIB was independent of 
the bacterial type and the corresponding antibiotic resistance 
pattern. In contrast, the photosensitizer concentration and 
light parameters used for bacteria killing did not affect cell 
viability of human keratinocytes (therapeutic window). 
Thus, the study suggests that multiresistant bacteria can be 
safely and effectively killed by a combination of modified 
vitamin B2 molecules, oxygen and visible light, whereas 
normal skin cells survive [17]. 
Thakuri et al. show by their study, where riboflavin 
was excited by blue light, killing of S. aureus and P. 
aeruginosa [ 18 ]. In the O'Rourke's study was shown the 
killing of Bacillus subtilis [19,20]. In the study of Makdoumi 
K. et all riboflavin enhanced the antibacterial effect on the 
exposed MRSA strain for two different wavelengths of blue 
light - 412 and 450 nm. Using the higher dose, CFU 
reduction was 99% and 98%, respectively, for 412 and 
450 nm light. The bactericidal efficacy was high also in the 
deeper fluid layer (93%, higher dose). These findings 
suggest that blue light could be considered for possible 
implementation in deep corneal infections [21]. 
It was shown, that riboflavin/UV-A and 
pretreatment with amphotericin B allowed effectiveness 
against such fungal pathogens as C. albicans, Fusarium sp, 
and A. fumigatusas which may cause infection 
keratomycosis [22]. 
But, in the study of Tuncann G. et al where biofilm 
formation and antibiofilm activity were assessed using 
different photosensitizers and types of irradiation, was 
observed that riboflavin + UV treatment showed only 
minimal effect on the Staphylococcus aureus ATCC 35556, 
Staphylococcus epidermidis ATCC 35984, Candida 
albicans ATCC 90028, and Candida parapsilosis ATCC 
96142 comparing with green LED and rose bengal. The 
lowest biofilm inhibition (biofilm inhibition indexes) was 
measured in group with riboflavin + UV treatment compared 
with LED and rose bengal and red LED with methylene blue. 
The groups to which riboflavin + UV was applied showed no 
effect on biofilm formation in C. parapsilosis and only 
minimally reduced the formation of biofilm in S. aureus and 
S. epidermidis, and by 24.5% in C. albicans [23]. 
 
 
Riboflavin as a photosensitizer in viruses’ inactivation  
Vitamin B2, illuminated by UVA or visible light, 
has also been developed as a nucleic acid-binding agent to 
be used for photoinactivation of such nucleic acid-containing 
pathogens in plasma, platelets, and RBCs as viruses. Several 
studies have revealed the effectiveness of reduction in some 
viruses’ infectivity, including human immunodeficiency 
virus 1 (HIV-1), bovine viral diarrhea virus (BVDV), 
hepatitis B virus (HCV), pseudorabies virus [24,25].  
It was shown that riboflavin with ultraviolet light 
irradiation has a substantial impact on reduction of dengue 
viruses’ infectivity, that are emerging across the world pose 
a risk to transfusion safety.  After treatment (1·81 log 
reduction) for DENV-4 was observed followed by (1·71 log 
reduction) for DENV-3, (1·45 log reduction) for DENV-2 
and then (1·28 log reduction) for DENV-1. This study 
concluded that riboflavin and UV light may be an alternative 
approach for managing the risk of DENV transfusion 
transmission via the ability to inactivate DENV 1-4 in 
platelet concentrates [26]. 
On the subject of the risk of transfusion 
transmission, the study of Keil SD et all showed that 
riboflavin and UV light effectively reduced the titer of 
Middle East respiratory syndrome coronavirus (MERS-
CoV) in human plasma products to below the limit of 
detection, suggesting that the treatment process may reduce 
the risk of transfusion transmission of MERS-CoV [27].  
The one more study is on the virus reduction 
technology used for blood and plasma.  In this study was 
obtained plasma from recovered patients after Ebolavirus 
(EBOV) infection, which is called "convalescent plasma, 
and is an effective treatment for active disease available in 
endemic areas. Whereas this type of plasma carries the risk 
of introducing other pathogens, including other strains of 
EBOV it must undergo the pathogen reduction process, but 
that which can save protective antivirus antibody titers. The 
«riboflavin+UV» application reduced ebolavirus (EBOV) 
titers to nondetectable levels in both nonhuman primate 
serum (≥2.8- to 3.2-log reduction) and human whole blood 
(≥3.0-log reduction) without decreasing protective antibody 
titers in human plasma. Thus, in vivo testing to determine 
whether UV+RB can improve convalescent blood product 
safety is indicated [28,29]. 
 
Riboflavin as a photosensitizer became a part of 
pathogen reduction technology 
 
Thus, the «riboflavin+UVB» system has found their 
application in pathogen reduction technology – «Mirasol»® 
Pathogen Reduction Technology (PRT) system («Terumo 
BCT Inc.», Lakewood, USA), which is used for blood and 
plasma before transfusion. [30]. 
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After obtaining a large amount of evidences of 
antimicrobial activity of «riboflavin+UVB», the focus has 
shifted to safety of its application and some possible 
alterations, which may following occur in platelets and 
plasma.  
The study of Abonnenc M. et all revealed that 
Mirasol®-treated platelets exhibit enhanced storage lesions 
compared to controls (increase of activation markers and 
glycolysis rate, lower hypotonic shock and double-agonist 
activation responses, and decrease of total antioxidant 
capacity). Authors also confirmed that the UV radiation 
alone is causing platelet lesions. Riboflavin tends to have an 
intracellular protective role while it decreases the 
extracellular antioxidant defenses. In this study were found 
some benefits of platelet additive solutions containing 
potassium and magnesium, which were confirmed to reduce 
the extent of storage lesions [31]. 
In the new study of Hermida-Nogueira et all were 
identified a high number of proteins related to platelet 
activation and platelet storage lesion that could have a role 
in possible transfusion adverse reactions. In this study 151 
proteins were found up-regulated at day 7 of storage after 
«Mirasol»® treatment. This group of proteins includes C-C 
motif chemokine ligand 5 (CCL5) and platelet factor 4, 
chemokines with ability to attract neutrophils and 
monocytes, which could generate transfusion adverse 
reactions. In addition, other glycoproteins and platelet 
activation markers were also found elevated at day 7. 
Proteins related to glycolysis and lactate production were 
found altered with high fold changes, showing a deregulation 
of platelet metabolism at day 7. The obtained results provide 
novel information about possible effects of platelet-derived 
EVs on transfusion adverse reactions. 
 
Riboflavin as an antitumor agent in photodynamic 
therapy 
Riboflavin has been thought to be a promising 
antitumoral agent in photodynamic therapy, though the 
further application of the method was limited by the unclear 
molecular mechanism. Some article reveal that riboflavin is 
able to recognize G–T mismatch specifically and induce 
single-strand breaks in duplex DNA targets efficiently under 
irradiation. In the presence of riboflavin, the photo-
irradiation could induce the death of tumor cells that are 
defective in mismatch repair system selectively, highlighting 
the G–T mismatch as potential drug target for malignant 
cells. Moreover, riboflavin is a promising leading compound 
for further drug design due to its inherent specific 
recognition of the G–T mismatch [32].  
Several studies reveal that of PDT-mediated 
cytotoxicity occur in three ways: apoptotic, necrotic and 
autophagy-associated cell death.  Some findings, show that 
certain PDT techniques acting via inducing of apoptotic cell 
death that is highly immunogenic and can stimulate 
antitumor immunity [33]. 
In the study of Akasov et al. a water-soluble form 
of riboflavin - flavin mononucleotide (FMN) – was shown as 
a promising agent for photodynamic therapy of melanoma. 
Blue light irradiation with dose 5 J/cm2 of melanoma cells 
pre-incubated with FMN led to cell death through apoptosis. 
Thus, the IC50 values of human melanoma A375, Mel IL, 
and Mel Z cells were in a range of FMN concentration 10 – 
30 µM that can be achieved in tumor tissue under systemic 
administration. Melanoma xenograft regression in mice was 
observed as a result of intravenous injection of FMN 
followed by blue-light irradiation of tumor site. The 
inhibition of tumor growth was 85 – 90 % within 50 days 
after PDT treatment [34]. 
 
Corneal collagen cross-linking with riboflavin as 
photodynamic therapy in the management of infectious 
keratitis 
Infectious keratitis is a potentially blinding ocular 
disease of the cornea. Besides antimicrobial drugs, the use of 
corneal collagen cross-linking (CXL) as photodynamic 
therapy (PDT) is also considered as potential alternative in 
the management of infectious keratitis [35,36]. Thus, CXL has 
also been described as riboflavin-UVA-photodynamic-
inactivation (riboflavin-UVA-PDI) [37]. 
Skaat A. et al presented the data when the 
adjunctive use of riboflavin/UVA photochemical therapy 
has a positive effect on refractory infectious keratitis. A 
retrospective analysis was performed of an interventional 
case series in which 6 eyes of 6 patients with severe 
infectious keratitis, all of whom were refractive to multidrug 
conventional therapy, were treated with riboflavin/UVA. In 
the result five of the 6 patients showed rapid reduction in 
symptoms and decreased infiltrate size after riboflavin/UVA 
photochemical therapy. Signs of infection and inflammation 
mostly resolved within 1 to 2 weeks after the treatment. 
Despite this therapy, one patient continued to deteriorate, 
and penetrating keratoplasty was performed. The treatment 
was claimed to be safe and effective and should be 
considered as part of the first-line therapy in severe cases of 
infectious keratitis [38]. 
The study of Song X et al revealed the impact of 
cross-linking (CXL) on viability, apoptosis, proliferation, 
activation, and cytokine secretion (FGFb, HGF, TGFβ1, 
VEGF, KGF, IL-1β, IL-6, and IL-8) of human keratoconus 
(KC) keratocytes, in vitro. Keratocytes were underwent 
UVA illumination (370 nm, 2 J/cm2) during exposure to 
0.1% riboflavin and 20% Dextran. Results reveal that 24 
hours after CXLcross-linking decreases viability, triggers 
apoptosis, and inhibits proliferation, without an impact on 
multipotent hematopoietic stem cell transformation and 
myofibroblastic transformation of KC keratocytes. CXL 
triggers FGFb secretion of KC keratocytes transiently (5 
hours), normalizing after 24 hours [39]. 
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Riboflavin, besides its key role in providing cellular 
metabolism in humans and animals, is used as a compound 
of antimicrobial photodynamic therapy (aPDT) owing to its 
photosensitizing capability. PDT is a promising approach for 
the photoinactivation of pathogens in blood and blood 
derivatives. It has been reported, that the advantage of 
antimicrobial photodynamic therapy is that there are no 
resistant strains to it. Flavins are photoreducible and photon-
induced excitation of them in the ultraviolet-blue (UV-blue) 
spectral band can lead to formation of either singlet oxygen 
via energy transfer to environmental oxygen, or hydrogen 
peroxide and derivatives via radicalisation – altogether 
termed reactive oxygen species (ROS) and used hereafter. 
Exactly the ROS production property of riboflavin is used 
for antiviral and antibacterial disinfection; for strengthening 
the corneal tissue in photorefractive surgery by the ROS-
induced collagen cross-linking. Several studies reveal 
the antimicrobial photodynamic potential of riboflavin 
irradiated with the ultraviolet-blue and with visible light 
against methicillin resistant Staphylococcus aureus, 
Staphylococcus epidermidis, enterohemorrhagic Escherichia 
coli, Pseudomonas aeruginosa, Acinetobacter baumannii 
and Bacillus subtilis in vitro. It was shown, 
that riboflavin/UV-A and allowed effectiveness against such 
fungal pathogens as Candida albicans, Candida 
parapsilosis, Fusarium spр, and A. fumigatusas which may 
cause infection keratomycosis.  The photoilluminated 
riboflavin significantly reduced the activity of superoxide 
dismutase (SOD) and reduced the level of cellular 
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antioxidant metabolite - glutathione (GSH). Along with that 
the specific activity of glutathione S-transferase (GST) - 
which is involved in detoxification process - was increased 
significantly in cells exposed to photoilluminated riboflavin. 
Riboflavin, illuminated by UVA or visible light, has also 
been developed as a nucleic acid-binding agent to be used for 
photoinactivation of such nucleic acid-containing pathogens 
in plasma, platelets, and RBCs as viruses. Several studies 
have revealed the effectiveness of reduction in some viruses’ 
infectivity, including human immunodeficiency virus 1 
(HIV-1), bovine viral diarrhea virus (BVDV), hepatitis B 
virus (HCV), pseudorabies virus. Thus, the 
«riboflavin+UVB» system has found their application in 
pathogen reduction technology – «Mirasol»® Pathogen 
Reduction Technology (PRT) system. Riboflavin has been 
thought to be a promising antitumoral agent in photodynamic 
therapy, though the further application of the method was 
limited by the unclear molecular mechanism. Several studies 
reveal that of PDT-mediated cytotoxicity occur in three 
ways: apoptotic, necrotic and autophagy-associated cell 
death.  Some findings, show that certain PDT techniques 
acting via inducing of apoptotic cell death that is highly 
immunogenic and can stimulate antitumor immunity. Thus, 
we can conclude that, the «riboflavin+UVB» system is 
suitable for photoinactivation of bacteria, fungi and viruses 
and has a potential in antitumor treatment strategies. Further 
studies will reveal more and more aspects of riboflavin 
capabilities. 
Keywords: riboflavin, photodynamic, 
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